サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1751006

全身麻酔薬の世界市場レポート 2025年

General Anesthesia Drugs Global Market Report 2025

出版日
ページ情報
英文 175 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.35円
全身麻酔薬の世界市場レポート 2025年
出版日: 2025年06月17日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

全身麻酔薬の市場規模は、今後数年間で安定した成長が見込まれます。2029年にはCAGR3.9％で60億8,000万米ドルに成長します。予測期間中の成長は、デジタルヘルスソリューションへの注目の高まり、外科手術の増加、世界人口の増加、心血管疾患の有病率の増加、高度モニタリングシステムへの投資の増加に起因すると考えられます。予測期間に予想される主な動向には、医療技術の発展、新規薬剤製剤の開発、麻酔デリバリーにおけるロボット工学の統合、薬剤分子の革新、麻酔関連技術の著しい進歩などがあります。

外科手術の増加は、全身麻酔薬市場の拡大を牽引すると予想されます。外科手術は、熟練した専門家が病気や怪我、異常を治療するために行う医療行為であり、通常、内部構造にアクセスするための切開や特殊な器具の使用を必要とします。外科的処置の急増は、慢性疾患の有病率の上昇に起因するところが大きく、その多くは効果的な治療のために外科的介入を必要とします。全身麻酔薬は、このような手術において、意識不明を誘発し痛みをなくすことで、患者が複雑な手術や侵襲的な手術の間中、動かず意識不明でいられるようにするという重要な役割を担っています。例えば、2024年6月、米国を拠点とする低侵襲手術を監督する非営利団体である米国形成外科学会は、2023年中の手術件数が2022年の2％増から7％増になると報告しました。その結果、外科手術の頻度の増加が全身麻酔薬市場の成長に拍車をかけています。

全身麻酔薬市場の主要企業は、患者の安全性を高め、回復時間を早め、手術効率を高める短時間作用型ベンゾジアゼピンなどの革新的ソリューションの開発に注力しています。ミダゾラムのような短時間作用型ベンゾジアゼピンは、即効性と作用時間の短さから、手技による鎮静のために一般的に使用されています。例えば、ドイツに本社を置くバイオテクノロジー企業PAION AGは、2023年8月、全身麻酔用のByfavo（レミマゾラム）をオランダで発売し、欧州での商業デビューを飾りました。Byfavoの特徴は、1～1.5分以内の素早い効果発現と11～14分以内の回復であり、短時間の手術に最適です。バイファボは、他のベンゾジアゼピン系麻酔薬と同様に、必要に応じて鎮静作用を速やかに打ち消すことができるフルマゼニルという逆転剤を有しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界全身麻酔薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
  • 最終用途産業の分析
  • 世界の全身麻酔薬市場：成長率分析
  • 世界の全身麻酔薬市場の実績：規模と成長、2019年～2024年
  • 世界の全身麻酔薬市場の予測：規模と成長、2024年～2029年、2034年
  • 世界全身麻酔薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

  • 世界の全身麻酔薬市場：薬剤別、実績と予測、2019年～2024年、2024年～2029年、2034年
  • セボフルラン
  • プロポフォール
  • デクスメデトミジン
  • レミフェンタニル
  • デスフルラン
  • ミダゾラム
  • その他の薬剤
  • 世界の全身麻酔薬市場：投与経路別、実績と予測、2019年～2024年、2024年～2029年、2034年
  • 静脈内
  • 吸入
  • 世界の全身麻酔薬市場：用途別、実績と予測、2019年～2024年、2024年～2029年、2034年
  • 心臓血管外科
  • 整形外科
  • 脳神経外科
  • 一般外科
  • 美容整形
  • その他の用途
  • 世界の全身麻酔薬市場：最終用途別、実績と予測、2019年～2024年、2024年～2029年、2034年
  • 病院
  • 外来手術センター
  • クリニック
  • その他のエンドユーザー
  • 世界の全身麻酔薬市場、セボフルランの種類別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
  • 吸入麻酔
  • 小児麻酔
  • 外来処置
  • 世界の全身麻酔薬市場、プロポフォールの種類別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
  • 導入麻酔
  • 維持麻酔
  • ICU鎮静
  • 世界の全身麻酔薬市場、デクスメデトミジンの種類別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
  • 処置鎮静
  • ICU鎮静
  • 術後鎮静
  • 世界の全身麻酔薬市場、レミフェンタニルの種類別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
  • オピオイド系麻酔
  • 短時間の外科手術
  • 疼痛管理
  • 世界の全身麻酔薬市場、デスフルランの種類別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
  • 吸入麻酔
  • 迅速な回復手順
  • 外来手術;
  • 世界の全身麻酔薬市場、ミダゾラムの種類別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
  • 術前鎮静
  • 処置鎮静
  • ICU鎮静
  • 世界の全身麻酔薬市場、その他の医薬品の種類別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
  • チオペンタールナトリウム
  • エトミデート
  • イソフルラン
  • ケタミン

第7章 地域別・国別分析

  • 世界の全身麻酔薬市場：地域別、実績と予測、2019年～2024年、2024年～2029年、2034年
  • 世界の全身麻酔薬市場：国別、実績と予測、2019年～2024年、2024年～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 全身麻酔薬市場：競合情勢
  • 全身麻酔薬市場：企業プロファイル
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Johnson and Johnson Services Inc Overview, Products and Services, Strategy and Financial Analysis
    • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • GlaxoSmithKline Plc Overview, Products and Services, Strategy and Financial Analysis
    • Boehringer Ingelheim Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Mylan NV.
  • Baxter International Inc.
  • Fresenius Kabi USA LLC
  • Sun Pharmaceutical Industries Ltd.
  • Eisai Co. Ltd.
  • Jiangsu Hengrui Pharmaceutical Co., Ltd.
  • Hikma Pharmaceuticals PLC
  • Aspen Global Incorporated
  • B. Braun SE
  • Claris Lifesciences Limited
  • Avet Pharmaceuticals Inc.
  • Piramal Critical Care
  • Safeline Pharmaceuticals（Pty）Ltd
  • Sini Pharma Pvt Ltd.
  • Rouzel Pharma Pvt Ltd

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 全身麻酔薬市場2029年：新たな機会を提供する国
  • 全身麻酔薬市場2029年：新たな機会を提供するセグメント
  • 全身麻酔薬市場2029年：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r34859

General anesthesia drugs are pharmacological agents that induce a controlled, reversible state of unconsciousness, analgesia, and immobility during surgical or medical procedures. These drugs work by depressing the central nervous system to prevent pain perception and the formation of memories related to the procedure. They are typically administered intravenously or via inhalation and are carefully adjusted to achieve the desired depth of anesthesia, ensuring patient safety and comfort throughout the operation.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main general anesthesia drugs include sevoflurane, propofol, dexmedetomidine, remifentanil, desflurane, midazolam, and other medications. Sevoflurane, a volatile anesthetic, is commonly used to both induce and maintain general anesthesia during surgical procedures. It can be administered intravenously or through inhalation and is applied in a variety of surgeries, including cardiovascular, orthopedic, neurosurgery, general, cosmetic, and others. This drug is used by a range of end-users, including hospitals, ambulatory surgical centers, clinics, and other healthcare facilities.

The general anesthesia drugs market research report is one of a series of new reports from The Business Research Company that provides general anesthesia drugs market statistics, including the general anesthesia drugs industry global market size, regional shares, competitors with the general anesthesia drugs market share, detailed general anesthesia drugs market segments, market trends, and opportunities, and any further data you may need to thrive in the general anesthesia drugs industry. This general anesthesia drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The general anesthesia drugs market size has grown steadily in recent years. It will grow from $5.01 billion in 2024 to $5.22 billion in 2025 at a compound annual growth rate (CAGR) of 4.2%. The growth during the historic period can be attributed to the growing preference for ambulatory surgical centers (ASCs), an increasing number of emergency and trauma cases, advancements in drug formulations, rising demand for customized anesthetic solutions, and the growing prevalence of cosmetic and elective surgeries.

The general anesthesia drugs market size is expected to see steady growth in the next few years. It will grow to $6.08 billion in 2029 at a compound annual growth rate (CAGR) of 3.9%. The growth during the forecast period can be attributed to a heightened focus on digital health solutions, an increase in surgical procedures, a rising global population, a growing prevalence of cardiovascular diseases, and increased investments in advanced monitoring systems. Key trends expected in the forecast period include advancements in medical technology, the development of novel drug formulations, the integration of robotics in anesthesia delivery, innovation in drug molecules, and significant progress in anesthesia-related technologies.

The growing number of surgical procedures is expected to drive the expansion of the general anesthesia drugs market. Surgical procedures involve medical operations conducted by skilled professionals to treat diseases, injuries, or abnormalities, typically requiring incisions or the use of specialized instruments to access internal structures. The surge in surgical procedures is largely attributed to the rising prevalence of chronic diseases, many of which necessitate surgical intervention for effective treatment. General anesthesia drugs play a crucial role in these procedures by inducing unconsciousness and eliminating pain, ensuring that patients remain immobile and unaware throughout complex or invasive surgeries. For example, in June 2024, the American Society of Plastic Surgeons, a US-based nonprofit overseeing minimally invasive procedures, reported a 7% increase in procedures during 2023-up from a 2% increase in 2022. As a result, the increasing frequency of surgical procedures is fueling the growth of the general anesthesia drugs market.

Leading companies in the general anesthesia drugs market are focusing on developing innovative solutions such as short-acting benzodiazepines to enhance patient safety, accelerate recovery times, and boost surgical efficiency. Short-acting benzodiazepines, such as midazolam, are commonly used for procedural sedation due to their rapid onset and short duration of action. For instance, in August 2023, PAION AG, a biotechnology company based in Germany, launched Byfavo (remimazolam) for general anesthesia in the Netherlands, marking its European commercial debut. Byfavo features a quick onset of effects within 1 to 1.5 minutes and recovery within 11 to 14 minutes, making it ideal for short-duration surgeries. It is primarily metabolized by hepatic esterases enzymes widely distributed throughout the body rather than the cytochrome P450 liver pathway. such as other benzodiazepines, Byfavo has a reversal agent, flumazenil, which can quickly counteract its sedative effects if necessary.

In January 2022, Dechra Pharmaceuticals Plc, a UK-based veterinary pharmaceutical company, acquired Isoflurane, USP Inhalant Anesthetic, and Sevoflurane, USP Inhalant Anesthetic from Halocarbon for an undisclosed sum. These products are widely used in veterinary hospitals and enhance Dechra's existing portfolio of sedatives and anesthetics. This acquisition strengthens the company's presence in the veterinary surgical and anesthesia space by providing high-quality, essential anesthetic solutions to the veterinary market. Halocarbon is a US-based manufacturer specializing in general anesthesia drugs.

Major players in the general anesthesia drugs market are Pfizer Inc., Johnson and Johnson Services Inc, AbbVie Inc., GlaxoSmithKline Plc, Boehringer Ingelheim, Mylan NV., Baxter International Inc., Fresenius Kabi USA LLC, Sun Pharmaceutical Industries Ltd., Eisai Co. Ltd., Jiangsu Hengrui Pharmaceutical Co., Ltd., Hikma Pharmaceuticals PLC, Aspen Global Incorporated, B. Braun SE, Claris Lifesciences Limited, Avet Pharmaceuticals Inc., Piramal Critical Care, Safeline Pharmaceuticals (Pty) Ltd, Sini Pharma Pvt Ltd., Rouzel Pharma Pvt Ltd.

North America was the largest region in the general anesthesia drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in general anesthesia drugs report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the general anesthesia drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The general anesthesia drugs market consists of sales of neuromuscular blocking agents, opioid analgesics, anesthesia adjuncts and reversal agents. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

General Anesthesia Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on general anesthesia drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for general anesthesia drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The general anesthesia drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Drug: Sevoflurane; Propofol; Dexmedetomidine; Remifentanil; Desflurane; Midazolam; Other Drugs
  • 2) By Route Of Administration: Intravenous; Inhaled
  • 3) By Application: Cardiovascular Surgery; Orthopedic Surgery; Neurosurgery; General Surgery; Cosmetic Surgery; Other Applications
  • 4) By End-Use: Hospitals; Ambulatory Surgical Centers; Clinics; Other End-Users
  • Subsegments:
  • 1) By Sevoflurane: Inhalation Anesthesia; Pediatric Anesthesia; Outpatient Procedures
  • 2) By Propofol: Induction Anesthesia; Maintenance Anesthesia; ICU Sedation
  • 3) By Dexmedetomidine: Procedural Sedation; ICU Sedation; Postoperative Sedation
  • 4) By Remifentanil: Opioid-Based Anesthesia; Short Surgical Procedures; Pain Management
  • 5) By Desflurane: Inhalation Anesthesia; Rapid Recovery Procedures; Outpatient Surgeries
  • 6) By Midazolam: Preoperative Sedation; Procedural Sedation; ICU Sedation
  • 7) By Other Drugs: Thiopental Sodium; Etomidate; Isoflurane; Ketamine
  • Companies Mentioned: Pfizer Inc.; Johnson and Johnson Services Inc; AbbVie Inc.; GlaxoSmithKline Plc; Boehringer Ingelheim
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. General Anesthesia Drugs Market Characteristics

3. General Anesthesia Drugs Market Trends And Strategies

4. General Anesthesia Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global General Anesthesia Drugs Growth Analysis And Strategic Analysis Framework

  • 5.1. Global General Anesthesia Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global General Anesthesia Drugs Market Growth Rate Analysis
  • 5.4. Global General Anesthesia Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global General Anesthesia Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global General Anesthesia Drugs Total Addressable Market (TAM)

6. General Anesthesia Drugs Market Segmentation

  • 6.1. Global General Anesthesia Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sevoflurane
  • Propofol
  • Dexmedetomidine
  • Remifentanil
  • Desflurane
  • Midazolam
  • Other Drugs
  • 6.2. Global General Anesthesia Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Intravenous
  • Inhaled
  • 6.3. Global General Anesthesia Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiovascular Surgery
  • Orthopedic Surgery
  • Neurosurgery
  • General Surgery
  • Cosmetic Surgery
  • Other Applications
  • 6.4. Global General Anesthesia Drugs Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Other End-Users
  • 6.5. Global General Anesthesia Drugs Market, Sub-Segmentation Of Sevoflurane, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Inhalation Anesthesia
  • Pediatric Anesthesia
  • Outpatient Procedures
  • 6.6. Global General Anesthesia Drugs Market, Sub-Segmentation Of Propofol, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Induction Anesthesia
  • Maintenance Anesthesia
  • ICU Sedation
  • 6.7. Global General Anesthesia Drugs Market, Sub-Segmentation Of Dexmedetomidine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Procedural Sedation
  • ICU Sedation
  • Postoperative Sedation
  • 6.8. Global General Anesthesia Drugs Market, Sub-Segmentation Of Remifentanil, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Opioid-Based Anesthesia
  • Short Surgical Procedures
  • Pain Management
  • 6.9. Global General Anesthesia Drugs Market, Sub-Segmentation Of Desflurane, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Inhalation Anesthesia
  • Rapid Recovery Procedures
  • Outpatient Surgeries;
  • 6.10. Global General Anesthesia Drugs Market, Sub-Segmentation Of Midazolam, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Preoperative Sedation
  • Procedural Sedation
  • ICU Sedation
  • 6.11. Global General Anesthesia Drugs Market, Sub-Segmentation Of Other Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Thiopental Sodium
  • Etomidate
  • Isoflurane
  • Ketamine

7. General Anesthesia Drugs Market Regional And Country Analysis

  • 7.1. Global General Anesthesia Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global General Anesthesia Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific General Anesthesia Drugs Market

  • 8.1. Asia-Pacific General Anesthesia Drugs Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific General Anesthesia Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific General Anesthesia Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific General Anesthesia Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China General Anesthesia Drugs Market

  • 9.1. China General Anesthesia Drugs Market Overview
  • 9.2. China General Anesthesia Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China General Anesthesia Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China General Anesthesia Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India General Anesthesia Drugs Market

  • 10.1. India General Anesthesia Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India General Anesthesia Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India General Anesthesia Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan General Anesthesia Drugs Market

  • 11.1. Japan General Anesthesia Drugs Market Overview
  • 11.2. Japan General Anesthesia Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan General Anesthesia Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan General Anesthesia Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia General Anesthesia Drugs Market

  • 12.1. Australia General Anesthesia Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia General Anesthesia Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia General Anesthesia Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia General Anesthesia Drugs Market

  • 13.1. Indonesia General Anesthesia Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia General Anesthesia Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia General Anesthesia Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea General Anesthesia Drugs Market

  • 14.1. South Korea General Anesthesia Drugs Market Overview
  • 14.2. South Korea General Anesthesia Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea General Anesthesia Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea General Anesthesia Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe General Anesthesia Drugs Market

  • 15.1. Western Europe General Anesthesia Drugs Market Overview
  • 15.2. Western Europe General Anesthesia Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe General Anesthesia Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe General Anesthesia Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK General Anesthesia Drugs Market

  • 16.1. UK General Anesthesia Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK General Anesthesia Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK General Anesthesia Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany General Anesthesia Drugs Market

  • 17.1. Germany General Anesthesia Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany General Anesthesia Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany General Anesthesia Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France General Anesthesia Drugs Market

  • 18.1. France General Anesthesia Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France General Anesthesia Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France General Anesthesia Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy General Anesthesia Drugs Market

  • 19.1. Italy General Anesthesia Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy General Anesthesia Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy General Anesthesia Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain General Anesthesia Drugs Market

  • 20.1. Spain General Anesthesia Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain General Anesthesia Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain General Anesthesia Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe General Anesthesia Drugs Market

  • 21.1. Eastern Europe General Anesthesia Drugs Market Overview
  • 21.2. Eastern Europe General Anesthesia Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe General Anesthesia Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe General Anesthesia Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia General Anesthesia Drugs Market

  • 22.1. Russia General Anesthesia Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia General Anesthesia Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia General Anesthesia Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America General Anesthesia Drugs Market

  • 23.1. North America General Anesthesia Drugs Market Overview
  • 23.2. North America General Anesthesia Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America General Anesthesia Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America General Anesthesia Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA General Anesthesia Drugs Market

  • 24.1. USA General Anesthesia Drugs Market Overview
  • 24.2. USA General Anesthesia Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA General Anesthesia Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA General Anesthesia Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada General Anesthesia Drugs Market

  • 25.1. Canada General Anesthesia Drugs Market Overview
  • 25.2. Canada General Anesthesia Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada General Anesthesia Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada General Anesthesia Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America General Anesthesia Drugs Market

  • 26.1. South America General Anesthesia Drugs Market Overview
  • 26.2. South America General Anesthesia Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America General Anesthesia Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America General Anesthesia Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil General Anesthesia Drugs Market

  • 27.1. Brazil General Anesthesia Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil General Anesthesia Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil General Anesthesia Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East General Anesthesia Drugs Market

  • 28.1. Middle East General Anesthesia Drugs Market Overview
  • 28.2. Middle East General Anesthesia Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East General Anesthesia Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East General Anesthesia Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa General Anesthesia Drugs Market

  • 29.1. Africa General Anesthesia Drugs Market Overview
  • 29.2. Africa General Anesthesia Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa General Anesthesia Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa General Anesthesia Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. General Anesthesia Drugs Market Competitive Landscape And Company Profiles

  • 30.1. General Anesthesia Drugs Market Competitive Landscape
  • 30.2. General Anesthesia Drugs Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Johnson and Johnson Services Inc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. GlaxoSmithKline Plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Boehringer Ingelheim Overview, Products and Services, Strategy and Financial Analysis

31. General Anesthesia Drugs Market Other Major And Innovative Companies

  • 31.1. Mylan NV.
  • 31.2. Baxter International Inc.
  • 31.3. Fresenius Kabi USA LLC
  • 31.4. Sun Pharmaceutical Industries Ltd.
  • 31.5. Eisai Co. Ltd.
  • 31.6. Jiangsu Hengrui Pharmaceutical Co., Ltd.
  • 31.7. Hikma Pharmaceuticals PLC
  • 31.8. Aspen Global Incorporated
  • 31.9. B. Braun SE
  • 31.10. Claris Lifesciences Limited
  • 31.11. Avet Pharmaceuticals Inc.
  • 31.12. Piramal Critical Care
  • 31.13. Safeline Pharmaceuticals (Pty) Ltd
  • 31.14. Sini Pharma Pvt Ltd.
  • 31.15. Rouzel Pharma Pvt Ltd

32. Global General Anesthesia Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The General Anesthesia Drugs Market

34. Recent Developments In The General Anesthesia Drugs Market

35. General Anesthesia Drugs Market High Potential Countries, Segments and Strategies

  • 35.1 General Anesthesia Drugs Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 General Anesthesia Drugs Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 General Anesthesia Drugs Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
  • 250617_r34859_General_Anesthesia_Drugs_GMR_2025